Table 1.
PCR primers and product sizes for the detection of carbapenemases among 12 XDR-AB strains
Fig 1.
Pulsed-field gel electrophoresis analysis of genomic DNA from the 12 tested strains of Acinetobacter baumannii.
Table 2.
Susceptibilities and molecular characteristics of 12 XDR-AB strainsa.
Table 3.
Efficacies of antibiotic monotherapies after 24 and 48 h of treatment vs results for untreated animalsa.
Table 4.
Comparison of the efficacies of colistin combinations vs monotherapies after 24 and 48 h of treatmenta.
Fig 2.
Comparison of the efficacies of colistin-fusidic acid combination vs other combinations after 24 and 48 h of treatment.
CST, colistin; MER, meropenem; TIG, tigecycline; FOS, fosfomycin; FD, fusidic acid; RIF, rifampin; SUL, sulbactam. Δlog means the log10 recovered CFU of other combinations minus the log10 recovered CFU of colistin-fusidic acid combination.
Fig 3.
Comparison of the efficacies of colistin-rifampin combination vs other combinations after 24 and 48 h of treatment.
CST, colistin; MER, meropenem; TIG, tigecycline; FOS, fosfomycin; FD, fusidic acid; RIF, rifampin; SUL, sulbactam. Δlog means the log10 recovered CFU of other combinations minus the log10 recovered CFU of colistin-rifampin combination.